// archives

Updated: FDA committee recommends Truvada’s approval as PrEP

The U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee recommended Thursday that the supplemental application for Gilead Sciences’ HIV drug Truvada (a combination of emtricitabine plus tenofovir, or TDF-FTC) as pre-exposure prophylaxis (PrEP) be approved for high-risk, HIV-negative individuals to reduce the risk of sexually acquired HIV infection. The panel of medical experts, [...]

Accordia Foundation Measures Impact of Capacity-Building Programs

Global health advocates discussed the findings of an ongoing study measuring the effectiveness of infectious disease training programs at a recent briefing hosted by The Accordia Global Health Foundation. The Integrated Infectious Disease Capacity-Building Evaluation (IDCAP) is a three-year program funded by the Bill & Melinda Gates Foundation with the goal of evaluating training programs [...]

Global Fund announces additional $1.6 billion at its disposal through 2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria estimates an additional $1.6 billion in funding will be available in the 2012-2014 period, according to a press release issued Wednesday by the organization. “The new forecast is a result of strategic decisions made by the Board, freeing up funds that can be invested in countries [...]

PDPs agree to jointly develop new TB vaccine candidate

Aeras and the Infectious Disease Research Institute (IDRI) – two non-profit product development partnerships (PDPs) – announced Wednesday they will be joining together to develop IDRI’s novel tuberculosis (TB) vaccine candidate ID93/GLA-SE. The compound contains an IDRI-designed recombinant fusion-protein antigen (a protein substance foreign to the body that stimulates the immune system’s production of antibodies [...]

Rwanda study: AIDS funding influx does not hurt response to other health issues

Despite fears that disproportionate resources devoted to HIV have crowded out other health services, global HIV/AIDS program funding does not subtract from other health issues, according to a study that appeared in the May edition of the American Journal of Tropical Medicine and Hygiene. Experts have disagreed over whether money injected into the global HIV/AIDS [...]

PEPFAR releases report to Congress, an update on drug-resistant TB in India, and more…

The following “What We’re Reading” selection is a collection of articles, commentary and resources making headlines recently in global health news. PEPFAR releases 8th annual report to Congress: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program delivered its 8th annual report to Congress recently. The five-page document outlines the program’s progress as of [...]

Follow us

Blog Archives

Categories

Global Health Expert Interviews

Science Speaks on Twitter